Advanced search
Publication Cover
Acta Oncologica Volume 48, 2009 - Issue 6
Journal homepage
2,688
Views
72
CrossRef citations to date
0
Altmetric
Original Article

Persistent neuropathy after treatment with cisplatin and oxaliplatin

Elke E. M. Brouwers Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066, EC, Amsterdam, The NetherlandsCorrespondence[email protected]
,
Alwin D. R. Huitema Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066, EC, Amsterdam, The Netherlands
,
Willem Boogerd Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066, EC, Amsterdam, The Netherlands; Department of Medical Oncology and Neuro-oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands
,
Jos H. Beijnen Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066, EC, Amsterdam, The Netherlands; Beta faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Section of Drug Toxicology, Utrecht University, P.O. Box 80082, 3508, TB, Utrecht, The Netherlands
&
Jan H. M. Schellens Department of Medical Oncology and Neuro-oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands; Beta faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Section of Drug Toxicology, Utrecht University, P.O. Box 80082, 3508, TB, Utrecht, The Netherlands
Pages 832-841 | Received 02 Sep 2008, Published online: 13 Aug 2009

Citations (72)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Filiz Kazak, Pınar Peker Akalın, Gül Fatma Yarım, Nuri Başpınar, Özgür Özdemir, Mehmet Burak Ateş, Muhammed Enes Altuğ & Mehmet Zeki Yılmaz Deveci. (2022) Protective effects of nobiletin on cisplatin induced neurotoxicity in rats. International Journal of Neuroscience 132:5, pages 531-537.
Read now
Paola Alberti. (2019) Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence. Expert Opinion on Drug Metabolism & Toxicology 15:6, pages 487-497.
Read now
L. M. Soveri, A. Lamminmäki, U. A. Hänninen, M. Karhunen, P. Bono & P. Osterlund. (2019) Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy. Acta Oncologica 58:4, pages 398-406.
Read now
Yasser A. Khadrawy, Mayada M. El-Gizawy, Safwa M. Sorour, Hussein G. Sawie & Eman N. Hosny. (2019) Effect of curcumin nanoparticles on the cisplatin-induced neurotoxicity in rat. Drug and Chemical Toxicology 42:2, pages 194-202.
Read now
Erel Icel, Turgay Uçak, Burcu Agcayazi, Yücel Karakurt, Hayati Yilmaz, Ferda Keskin Çimen & Halis Süleyman. (2018) Effects of Pycnogenol on cisplatin-induced optic nerve injury: an experimental study. Cutaneous and Ocular Toxicology 37:4, pages 396-400.
Read now
Jan Oldenburg & Sophie D. Fosså. (2009) Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations. Acta Oncologica 48:6, pages 804-806.
Read now

Articles from other publishers (66)

Doaa Shaaban Mohamed, Olfat Shehata, Mai Mohamed Labib & Nema Sayed Shaban. (2023) Integrated in vivo and in silico evaluation of sweet basil oil as a protective agent against cisplatin-induced neurotoxicity in mice. Beni-Suef University Journal of Basic and Applied Sciences 12:1.
Crossref
Takashiro Akitsu, Dobrina Tsvetkova, Yuma Yamamoto, Daisuke Nakane & Irena Kostova. (2023) From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs. Current Pharmaceutical Design 29:22, pages 1747-1774.
Crossref
Abdulla M.A. Mahmoud, Eman M. Mantawy, Sara A. Wahdan, Ramy M. Ammar & Ebtehal El-Demerdash. (2023) Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: Imperative roles of AMPK/Akt/CREB/ BDNF signaling cascades. Biomedicine & Pharmacotherapy 159, pages 114238.
Crossref
Eman A. Khalil, Hamdy Swelim, Hala El-Tantawi & Ahmed Abdellatif. (2023) Sea urchin (Diadema savignyi) extract as a novel protective agent against cisplatin induced neurotoxicity in rats. BMC Pharmacology and Toxicology 24:1.
Crossref
Caner Yildirim, Sibel Cangi, Mustafa Orkmez, Senay Gorucu Yilmaz, Mehmet Akif Bozdayı, Hatice Yamaner & Sena Cevik. (2022) Sinapic Acid Attenuated Cisplatin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and İnflammation with GPX4-Mediated NF-kB Modulation. Cardiovascular Toxicology 23:1, pages 10-22.
Crossref
Andrea M.P. Romani. (2022) Cisplatin in cancer treatment. Biochemical Pharmacology 206, pages 115323.
Crossref
Aina Calls, Abel Torres‐Espin, Marc Tormo, Laura Martínez‐Escardó, Núria Bonet, Ferran Casals, Xavier Navarro, Víctor J. Yuste, Esther Udina & Jordi Bruna. (2022) A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice. Annals of Clinical and Translational Neurology 9:12, pages 1985-1998.
Crossref
Gabriella Horvath, Dora Reglodi, Eszter Fabian & Balazs Opper. (2022) Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death. International Journal of Molecular Sciences 23:9, pages 4953.
Crossref
Ozlem Kara, Emin Kaymak & Birkan Yakan. (2022) Protective effect of edaravone on cisplatin-induced injury in rat ovary. Archives of Gynecology and Obstetrics 306:5, pages 1673-1678.
Crossref
Jordi Casanova-Mollà. 2022. Neurotoxicity - New Advances. Neurotoxicity - New Advances.
Caner Yildirim, Sena Cevik, Hatice Yamaner, Mustafa Orkmez, Omer Eronat, Mehmet Akif Bozdayı & Mehmet Erdem. (2022) Boric acid improves the behavioral, electrophysiological and histological parameters of cisplatin-induced peripheral neuropathy in rats. Journal of Trace Elements in Medicine and Biology 70, pages 126917.
Crossref
Loredana G. Marcu. (2022) Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds. Pharmaceuticals 15:2, pages 255.
Crossref
Yan-Wen Liu, Ying-Jung Chen, Yen-Hao Chen & Ming-Yen Tsai. (2022) Therapeutic Efficacy of Traditional Chinese Medicine Syndrome-Based Formulae to Neuropathic Pain Caused by Chemotherapy. Integrative Cancer Therapies 21, pages 153473542211210.
Crossref
Naihe Liu, Sun Zhou, Opeyemi Joshua Olatunji & Yong Wu. (2022) Nucleosides rich extract from Cordyceps cicadae alleviated cisplatin-induced neurotoxicity in rats: A behavioral, biochemical and histopathological study. Arabian Journal of Chemistry 15:1, pages 103476.
Crossref
Azza Attia, Cecil Matta, Reda ElMazoudy & Hanan Khalifa. (2021) Cisplatin-induced neurotoxicity in cerebellar cortex of male mice involves oxidative stress and histopathology. The Journal of Basic and Applied Zoology 82:1.
Crossref
Muhammad Zakria, Nasir Ahmad, Lina Tariq Al Kury, Abdullah Alattar, Zia Uddin, Sami Siraj, Shakir Ullah, Reem Alshaman, Muhammad Imran Khan & Fawad Ali Shah. (2021) RETRACTED: Melatonin rescues the mice brain against cisplatin-induced neurodegeneration, an insight into antioxidant and anti-inflammatory effects. NeuroToxicology 87, pages 1-10.
Crossref
R. Bonomo & G. Cavaletti. (2021) Clinical and biochemical markers in CIPN: A reappraisal. Revue Neurologique 177:8, pages 890-907.
Crossref
Ian R. Kleckner, Todd A. Jusko, Eva Culakova, Kaitlin Chung, Amber S. Kleckner, Matthew Asare, Julia E. Inglis, Kah Poh Loh, Luke J. Peppone, Jessica Miller, Marianne Melnik, Samer Kasbari, Deborah Ossip & Karen M. Mustian. (2021) Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy. Breast Cancer Research and Treatment 189:2, pages 521-532.
Crossref
Rosario Privitera & Praveen Anand. (2021) Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN). Current Opinion in Supportive & Palliative Care 15:2, pages 125-131.
Crossref
Aina Calls, Abel Torres-Espin, Xavier Navarro, Victor J Yuste, Esther Udina & Jordi Bruna. (2021) Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response. Neuro-Oncology 23:1, pages 88-99.
Crossref
Aysel Cetinkaya-Fisgin, Xinghua Luan, Nicole Reed, Ye Eun Jeong, Byoung Chol Oh & Ahmet Hoke. (2020) Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation. Scientific Reports 10:1.
Crossref
Kristine Bennedsgaard, Lise Ventzel, Andreas C. Themistocleous, David L. Bennett, Anders B. Jensen, Anni R. Jensen, Niels T. Andersen, Troels S. Jensen, Hatice Tankisi & Nanna B. Finnerup. (2020) Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy. Cancer Medicine 9:14, pages 5114-5123.
Crossref
Neife Aparecida Guinaim dos Santos, Rafaela Scalco Ferreira & Antonio Cardozo dos Santos. (2020) Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food and Chemical Toxicology 136, pages 111079.
Crossref
Han-Wei Huang, Pei-Ying Wu, Pei-Fang Su, Chung-I Li, Yu-Min Yeh, Peng-Chan Lin, Keng-Fu Hsu, Meng-Ru Shen, Jang-Yang Chang & Chou-Ching K. Lin. (2020) A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy. Disease Markers 2020, pages 1-8.
Crossref
Alex Molassiotis, Hui Lin Cheng, Violeta Lopez, Joseph S. K. Au, Alexandre Chan, Aishwarya Bandla, K. T. Leung, Y. C. Li, K. H. Wong, Lorna K. P. Suen, Choi Wan Chan, Janelle Yorke, Carole Farrell & Raghav Sundar. (2019) Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer 19:1.
Crossref
J. Matt McCraryDavid GoldsteinTerry TrinhHannah C. TimminsTiffany LiJasmine MenantMichael FriedlanderCraig R. LewisMark HertzbergSiobhan O’NeillTracy KingAnnmarie Bosco, Michelle Harrison & Susanna B. Park. (2019) Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments. Journal of the National Comprehensive Cancer Network 17:8, pages 949-955.
Crossref
L. Leermakers, S. Döking, B. Thewes, A. M. J. Braamse, M. F. M. Gielissen, J. H. W. de Wilt, E. H. Collette, J. Dekker & J. B. Prins. (2018) Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors. BMC Cancer 18:1.
Crossref
Eric I Chang, Michael I Rose, Kristie Rossi & Andrew I Elkwood. (2018) Microneurosurgical treatment options in peripheral nerve compression syndromes after chemotherapy and radiation treatment. Journal of Surgical Oncology 118:5, pages 793-799.
Crossref
Olatunde Owoeye, Isaac A. Adedara & Ebenezer O. Farombi. (2018) Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats. Biomedicine & Pharmacotherapy 102, pages 375-384.
Crossref
Ian R. Kleckner, Charles Kamen, Jennifer S. Gewandter, Nimish A. Mohile, Charles E. Heckler, Eva Culakova, Chunkit Fung, Michelle C. Janelsins, Matthew Asare, Po-Ju Lin, Pavan S. Reddy, Jeffrey Giguere, Jeffrey Berenberg, Shelli R. Kesler & Karen M. Mustian. (2017) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Supportive Care in Cancer 26:4, pages 1019-1028.
Crossref
Rachel M McQuade, Vanesa Stojanovska, Rhian Stavely, Cara Timpani, Aaron C Petersen, Raquel Abalo, Joel C Bornstein, Emma Rybalka & Kulmira Nurgali. (2018) Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15. British Journal of Pharmacology 175:4, pages 656-677.
Crossref
JB Delmotte, H Beaussier, N Auzeil, F Massicot, O Laprévote, E Raymond & F Coudoré. (2018) Is quantitative sensory testing helpful in the management of oxaliplatin neuropathy? a two-year clinical study. Cancer Treatment and Research Communications 17, pages 31-36.
Crossref
Mashal M. Almutairi, Wael A. Alanazi, Musaad A. Alshammari, Moureq Rashed Alotaibi, Ali R. Alhoshani, Salim Salah Al-Rejaie, Mohamed M. Hafez & Othman A. Al-Shabanah. (2017) Neuro-protective effect of rutin against Cisplatin-induced neurotoxic rat model. BMC Complementary and Alternative Medicine 17:1.
Crossref
Jeremy N. Pulvers & Gavin Marx. (2017) Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review. Asia-Pacific Journal of Clinical Oncology 13:6, pages 345-355.
Crossref
J. Cliff, A.L. Jorgensen, R. Lord, F. Azam, L. Cossar, D.F. Carr & M. Pirmohamed. (2017) The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 120, pages 127-140.
Crossref
Kazuaki Nagasaka, Kazunori Yamanaka, Shinya Ogawa, Hiroyuki Takamatsu & Noriyuki Higo. (2017) Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity. Scientific Reports 7:1.
Crossref
Hiroyuki Tanishima, Toshiji Tominaga, Masamichi Kimura, Tsunehiro Maeda, Yasutsugu Shirai & Tetsuya Horiuchi. (2016) Hyperacute peripheral neuropathy is a predictor of oxaliplatin-induced persistent peripheral neuropathy. Supportive Care in Cancer 25:5, pages 1383-1389.
Crossref
Ramin Rezaee, Amir Abbas Momtazi, Alireza Monemi & Amirhossein Sahebkar. (2017) Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacological Research 117, pages 218-227.
Crossref
Jing Wang, Xin-Sheng Zhang, Rong Tao, Jie Zhang, Lin Liu, Ying-Hai Jiang, Song-He Ma, Lin-Xia Song & Ling-Jie Xia. (2017) Upregulation of CX3CL1 mediated by NF-κB activation in dorsal root ganglion contributes to peripheral sensitization and chronic pain induced by oxaliplatin administration. Molecular Pain 13, pages 174480691772625.
Crossref
Kelly A Aromolaran & Peter A Goldstein. (2017) Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy. Molecular Pain 13, pages 174480691771469.
Crossref
Rafaela Scalco Ferreira, Neife Aparecida Guinaim dos Santos, Nádia Maria Martins, Laís Silva Fernandes & Antonio Cardozo dos Santos. (2016) Non-cytotoxic Concentration of Cisplatin Decreases Neuroplasticity-Related Proteins and Neurite Outgrowth Without Affecting the Expression of NGF in PC12 Cells. Neurochemical Research 41:11, pages 2993-3003.
Crossref
Erika Roddy & Sabine Mueller. (2015) Late Effects of Treatment of Pediatric Central Nervous System Tumors. Journal of Child Neurology 31:2, pages 237-254.
Crossref
Hongping Chen, Qinghua Wang, Danni Shi, Dongbo Yao, Lei Zhang, Junping Xiong & Baohua Xu. (2016) Celecoxib alleviates oxaliplatin-induced hyperalgesia through inhibition of spinal ERK1/2 signaling. Journal of Toxicologic Pathology 29:4, pages 253-259.
Crossref
Shu-Ping Jiang, Zhen-Dong Zhang, Lu-Mei Kang, Qing-Hua Wang, Lei Zhang & Hong-Ping Chen. (2016) Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion. Experimental Neurology 275, pages 11-16.
Crossref
Khaled El‐Shami, Kevin C. Oeffinger, Nicole L. Erb, Anne Willis, Jennifer K. Bretsch, Mandi L. Pratt‐Chapman, Rachel S. Cannady, Sandra L. Wong, Johnie Rose, April L. Barbour, Kevin D. Stein, Katherine B. Sharpe, Durado D. Brooks & Rebecca L. Cowens‐Alvarado. (2015) American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA: A Cancer Journal for Clinicians 65:6, pages 427-455.
Crossref
Timothy Gilligan. (2015) Quality of life among testis cancer survivors. Urologic Oncology: Seminars and Original Investigations 33:9, pages 413-419.
Crossref
Joanna E. Fardell, Janette Vardy, Lauren A. Monds & Ian N. Johnston. (2015) The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy. Behavioural Brain Research 291, pages 80-88.
Crossref
Pauline A. J. Vissers, Floortje Mols, Melissa S. Y. Thong, Frans Pouwer, Gerard Vreugdenhil & Lonneke V. van de Poll-Franse. (2015) The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry. Journal of Cancer Survivorship 9:3, pages 523-531.
Crossref
Alessia Chiorazzi, Sara Semperboni & Paola Marmiroli. (2015) Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity. Toxics 3:3, pages 304-321.
Crossref
Moon Ho Kim, Min Sik Hwang, Yoon Kyoo Park, Yerim Park, Yong Chel Ahn, Ho-Suk Oh & Heui-June Ahn. (2015) Paraneoplastic Guillain-Barré Syndrome in Small Cell Lung Cancer. Case Reports in Oncology 8:2, pages 295-300.
Crossref
Ergun Karavelioglu, Mehmet Gazi Boyaci, Nejdet Simsek, Mehmet Akif Sonmez, Rabia Koc, Mustafa Karademir, Mustafa Guven & Olcay Eser. (2015) Selenium protects cerebral cells by cisplatin induced neurotoxicity. Acta Cirurgica Brasileira 30:6, pages 394-400.
Crossref
Yassine Chtourou, Brahim Gargouri, Mohammed Kebieche & Hamadi Fetoui. (2015) Naringin Abrogates Cisplatin-Induced Cognitive Deficits and Cholinergic Dysfunction Through the Down-Regulation of AChE Expression and iNOS Signaling Pathways in Hippocampus of Aged Rats. Journal of Molecular Neuroscience 56:2, pages 349-362.
Crossref
Tulay Akman, Levent Akman, Oytun Erbas, Mustafa Cosan Terek, Dilek Taskiran & Aydin Ozsaran. (2015) The Preventive Effect of Oxytocin to Cisplatin-Induced Neurotoxicity: An Experimental Rat Model. BioMed Research International 2015, pages 1-5.
Crossref
Chiara Briani, Andreas A. Argyriou, Cristina Izquierdo, Roser Velasco, Marta Campagnolo, Paola Alberti, Barbara Frigeni, Mario Cacciavillani, Francesca Bergamo, Diego Cortinovis, Marina Cazzaniga, Jordi Bruna, Guido Cavaletti & Haralabos P. Kalofonos. (2015) Long‐term course of oxaliplatin‐induced polyneuropathy: a prospective 2‐year follow‐up study. Journal of the Peripheral Nervous System 19:4, pages 299-306.
Crossref
Susana Pereira, Filipa Fontes, Teresa Sonin, Teresa Dias, Maria Fragoso, José Castro-Lopes & Nuno Lunet. (2014) Neurological complications of breast cancer: study protocol of a prospective cohort study. BMJ Open 4:10, pages e006301.
Crossref
N.C. Miltenburg & W. Boogerd. (2014) Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treatment Reviews 40:7, pages 872-882.
Crossref
A. J. M. Beijers, F. Mols & G. Vreugdenhil. (2014) A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration. Supportive Care in Cancer 22:7, pages 1999-2007.
Crossref
Haydar Ali Erken, Emine Rabia Koç, Haşmet Yazıcı, Arzu Yay, Gözde Özge Önder & Saim Furkan Sarıcı. (2014) Selenium partially prevents cisplatin-induced neurotoxicity: A preliminary study. NeuroToxicology 42, pages 71-75.
Crossref
Susanna B. Park, David Goldstein, Arun V. Krishnan, Cindy S‐Y Lin, Michael L. Friedlander, James Cassidy, Martin Koltzenburg & Matthew C. Kiernan. (2013) Chemotherapy‐induced peripheral neurotoxicity: A critical analysis. CA: A Cancer Journal for Clinicians 63:6, pages 419-437.
Crossref
Leonardo Meneghin Mendonça, Carla da Silva Machado, Cristiane Cardoso Correia Teixeira, Luis Alexandre Pedro de Freitas, Maria de Lourdes Pires Bianchi & Lusânia Maria Greggi Antunes. (2013) Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. NeuroToxicology 34, pages 205-211.
Crossref
W. Grisold, G. Cavaletti & A. J. Windebank. (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology 14:suppl 4, pages iv45-iv54.
Crossref
Robert Raffa, Richard Langford, Joseph PergolizziJrJr, Frank Porreca & Ronald TallaridaJoseph PergolizziJrJr & Jo LeQuang. 2012. Chemotherapy-Induced Neuropathic Pain. Chemotherapy-Induced Neuropathic Pain 19 94 .
Andreas A. Argyriou, Jordi Bruna, Paola Marmiroli & Guido Cavaletti. (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Critical Reviews in Oncology/Hematology 82:1, pages 51-77.
Crossref
Brett Morrison & Vinay Chaudhry. (2012) Medication, Toxic, and Vitamin-Related Neuropathies. CONTINUUM: Lifelong Learning in Neurology 18, pages 139-160.
Crossref
Susanna B. ParkCindy S.Y. LinArun V. KrishnanDavid Goldstein, Michael L. Friedlander & Matthew C. Kiernan. (2011) Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility. The Oncologist 16:5, pages 708-716.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:3, pages i-xiii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.